Biology of Blood and Marrow Transplantation
Volume 15, Issue 5 , Pages 537-546 , May 2009

The Release of Soluble Factors Contributing to Endothelial Activation and Damage after Hematopoietic Stem Cell Transplantation Is Not Limited to the Allogeneic Setting and Involves Several Pathogenic Mechanisms

  • Marta Palomo

      Affiliations

    • Hemotherapy-Hemostasis Department, Centre de Diagnòstic Biomèdic, University of Barcelona, Barcelona, Spain
    • ,
  • Maribel Diaz-Ricart

      Affiliations

    • Hemotherapy-Hemostasis Department, Centre de Diagnòstic Biomèdic, University of Barcelona, Barcelona, Spain
    • ,
  • Carla Carbo

      Affiliations

    • Hemotherapy-Hemostasis Department, Centre de Diagnòstic Biomèdic, University of Barcelona, Barcelona, Spain
    • ,
  • Montserrat Rovira

      Affiliations

    • Stem Cell Transplantation Unit, Hematology Department, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clinic, University of Barcelona, Barcelona, Spain
    • ,
  • Francesc Fernandez-Aviles

      Affiliations

    • Stem Cell Transplantation Unit, Hematology Department, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clinic, University of Barcelona, Barcelona, Spain
    • ,
  • Gines Escolar

      Affiliations

    • Hemotherapy-Hemostasis Department, Centre de Diagnòstic Biomèdic, University of Barcelona, Barcelona, Spain
    • ,
  • Günther Eissner

      Affiliations

    • Cardiac Surgery, Grosshadern Medical Center, University of Munich, Munich, Germany
    • ,
  • Ernst Holler

      Affiliations

    • Abteilung Hämatologie Onkologie, Klinikum der Universität Regensburg, Regensburg, Germany
    • ,
  • Enric Carreras

      Affiliations

    • Stem Cell Transplantation Unit, Hematology Department, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clinic, University of Barcelona, Barcelona, Spain
    • Corresponding Author InformationCorrespondence and reprint requests: Enric Carreras, MD, Stem Cell Transplantation Unit, Hematology Department, Hospital Clinic, Villarroel 170, 08036 Barcelona, Spain.

Received 2 October 2008 ,Accepted 15 January 2009.

References 

  1. Ljungman P, Urbano-Ispizua A, Cavazzana-Calvo M, et al. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe. Bone Marrow Transplant. 2006;37:439–449
  2. Socie G, Salooja N, Cohen A, et al. Nonmalignant late effects after allogeneic stem cell transplantation. Blood. 2003;101:3373–3385
  3. Devergie A. Graft-versus-host disease. In:  Apperley J,  Carreras E,  Gluckman E, et al. editor. Haematopoietic Stem Cell Transplantation. Genova, Italy: Forum Service Editore; 2008;p. 218–233
  4. Cooke KR, Jannin A, Vincent H. The contribution of endothelial activation and injury to end-organ toxicity following allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2008;14:23–32
  5. Carreras E. Early complications after HSCT. In:  Apperley J,  Carreras E,  Gluckman E, et al. editor. Haematopoietic Stem Cell Transplantation. Genova, Italy: Forum Service Editore; 2008;p. 180–195
  6. Biedermann BC. Vascular endothelium and graft-versus-host disease. Best Pract Res Clin Haematol. 2008;21:129–138
  7. Spitzer TR. Engraftment syndrome following hematopoietic stem cell transplantation. Bone Marrow Transplant. 2001;27:893–898
  8. Eissner G, Lindner H, Behrends U, et al. Influence of bacterial endotoxin on radiation-induced activation of human endothelial cells in vitro and in vivo: protective role of IL-10. Transplantation. 1996;62:819–827
  9. Eissner G, Multhoff G, Gerbitz A, et al. Fludarabine induces apoptosis, activation, and allogenicity in human endothelial and epithelial cells: protective effect of defibrotide. Blood. 2002;100:334–340
  10. Biedermann BC, Sahner S, Gregor M, et al. Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft-versus-host disease. Lancet. 2002;359:2078–2083
  11. Tichelli A, Gratwohl A. Vascular endothelium as “novel” target of graft-versus-host disease. Best Pract Res Clin Haematol. 2008;21:139–148
  12. Matsuda Y, Hara J, Osugi Y, et al. Serum levels of soluble adhesion molecules in stem cell transplantation–related complications. Bone Marrow Transplant. 2001;27:977–982
  13. Nurnberger W, Michelmann I, Burdach S, et al. Endothelial dysfunction after bone marrow transplantation: increase of soluble thrombomodulin and PAI-1 in patients with multiple transplant-related complications. Ann Hematol. 1998;76:61–65
  14. Richard S, Seigneur M, Blann A, et al. Vascular endothelial lesion in patients undergoing bone marrow transplantation. Bone Marrow Transplant. 1996;18:955–959
  15. Salat C, Holler E, Kolb HJ, et al. Endothelial cell markers in bone marrow transplant recipients with and without acute graft-versus-host disease. Bone Marrow Transplant. 1997;19:909–914
  16. Woywodt A, Haubitz M, Buchholz S, et al. Counting the cost: markers of endothelial damage in hematopoietic stem cell transplantation. Bone Marrow Transplant. 2004;34:1015–1023
  17. Pihusch V, Rank A, Steber R, et al. Endothelial cell-derived microparticles in allogeneic hematopoietic stem cell recipients. Transplantation. 2006;81:1405–1409
  18. Woywodt A, Scheer J, Hambach L, et al. Circulating endothelial cells as a marker of endothelial damage in allogeneic hematopoietic stem cell transplantation. Blood. 2004;103:3603–3605
  19. Fuste B, Mazzara R, Escolar G, et al. Granulocyte colony-stimulating factor increases expression of adhesion receptors on endothelial cells through activation of p38 MAPK. Haematologica. 2004;89:578–585
  20. Serradell M, Diaz-Ricart M, Cases A, et al. Uremic medium causes expression, redistribution and shedding of adhesion molecules in cultured endothelial cells. Haematologica. 2002;87:1053–1061
  21. Jaffe EA, Nachman RL, Becker CG, et al. Culture of human endothelial cells derived from umbilical veins: identification by morphologic and immunologic criteria. J Clin Invest. 1973;52:2745–2756
  22. De Mey J, Moeremans M, Geuens G, et al. High-resolution light and electron microscopic localization of tubulin with the IGS (immunogold staining) method. Cell Biol Int Rep. 1981;5:889–899
  23. Scopsi L, Larsson LI, Bastholm L, et al. Silver-enhanced colloidal gold probes as markers for scanning electron microscopy. Histochemistry. 1986;86:35–41
  24. Muggli R, Baumgartner HR, Tschopp TB, et al. Automated microdensitometry and protein assays as a measure for platelet adhesion and aggregation on collagen-coated slides under controlled flow conditions. J Lab Clin Med. 1980;95:195–207
  25. Diaz-Ricart M, Tandon NN, Gomez-Ortiz G, et al. Antibodies to CD36 (GPIV) inhibit platelet adhesion to subendothelial surfaces under flow conditions. Arterioscler Thromb Vasc Biol. 1996;16:883–888
  26. Sakariassen KS, Aarts PA, de Groot PG, et al. A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel wall cells, their extracellular matrix, and purified components. J Lab Clin Med. 1983;102:522–535
  27. Diaz-Ricart M, Carretero M, Castillo R, et al. Digital image analysis of platelet–extracellular matrix interactions: studies in von Willebrand disease patients and aspirin-treated donors. Haemostasis. 1994;24:219–229
  28. Fuste B, Serradell M, Escolar G, et al. Erythropoietin triggers a signaling pathway in endothelial cells and increases the thrombogenicity of their extracellular matrices in vitro. Thromb Haemost. 2002;88:678–685
  29. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979;76:4350–4354
  30. Eissner G, Kohlhuber F, Grell M, et al. Critical involvement of transmembrane tumor necrosis factor-alpha in endothelial programmed cell death mediated by ionizing radiation and bacterial endotoxin. Blood. 1995;86:4184–4193
  31. Tichelli A, Bucher C, Rovo A, et al. Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation. Blood. 2007;110:3463–3471
  32. Tichelli A, Passweg J, Wojcik D, et al. Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the EBMT. Haematologica. 2008;93:1203–1210
  33. Fuste B, Escolar G, Marin P, et al. G-CSF increases the expression of VCAM-1 on stromal cells promoting the adhesion of CD34+ hematopoietic cells: studies under flow conditions. Exp Hematol. 2004;32:765–772
  34. Ganster A, Brucker I, Holler E, et al. In vitro monitoring of endothelial complications following hematopoietic allogeneic stem cell transplantation. Bone Marrow Transplant. 2004;33:355–357
  35. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood. 1994;84:2068–2101

 Financial disclosure: See Acknowledgments on page 545.

PII: S1083-8791(09)00058-5

doi: 10.1016/j.bbmt.2009.01.013

Biology of Blood and Marrow Transplantation
Volume 15, Issue 5 , Pages 537-546 , May 2009

Article Tools

* Image Usage & Resolution